Jan Johansson
Director/Board Member at Artery Therapeutics, Inc.
Net worth: 4 509 $ as of 2024-03-30
Profile
Jan O.
Johansson was the founder of Esperion Therapeutics, Inc. founded in 1998, where he held the title of Vice President-Clinical Affairs in 2001.
Currently, he is a Director at Artery Therapeutics, Inc., a Member of the American Heart Association, Inc., and a Member of the European Atherosclerosis Society.
In the past, he was the Chief Medical Officer at Nuvelo, Inc. in 2004, Vice President-Clinical, Research & Development at Lipid Sciences, Inc. in 2003, and Senior Vice President-Medical Affairs at Resverlogix Corp.
He also held the title of Associate Professor at Karolinska University Hospital.
Dr. Johansson received his graduate and doctorate degrees from Karolinska Institutet.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
RESVERLOGIX CORP.
0.04% | 2022-10-12 | 107,360 ( 0.04% ) | 4 509 $ | 2024-03-30 |
Jan Johansson active positions
Companies | Position | Start |
---|---|---|
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Corporate Officer/Principal | - |
European Atherosclerosis Society | Corporate Officer/Principal | - |
Artery Therapeutics, Inc.
Artery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Artery Therapeutics, Inc. is an American biotechnology company that operates in the field of medicine. The private company was founded by Hans Ageland. | Director/Board Member | 2011-02-15 |
Former positions of Jan Johansson
Companies | Position | End |
---|---|---|
Nuvelo, Inc. | Chief Tech/Sci/R&D Officer | 2003-12-31 |
Lipid Sciences, Inc.
Lipid Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA. | Chief Tech/Sci/R&D Officer | 2002-12-31 |
ESPERION THERAPEUTICS, INC. | Founder | 2000-12-31 |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Corporate Officer/Principal | - |
RESVERLOGIX CORP. | Chief Tech/Sci/R&D Officer | - |
Training of Jan Johansson
Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ESPERION THERAPEUTICS, INC. | Health Technology |
RESVERLOGIX CORP. | Health Technology |
Private companies | 6 |
---|---|
Nuvelo, Inc. | Health Technology |
Lipid Sciences, Inc.
Lipid Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA. | Commercial Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
European Atherosclerosis Society | |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Health Services |
Artery Therapeutics, Inc.
Artery Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Artery Therapeutics, Inc. is an American biotechnology company that operates in the field of medicine. The private company was founded by Hans Ageland. | Commercial Services |
- Stock Market
- Insiders
- Jan Johansson